Chlamydia trachomatis: the Persistent Pathogen
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Chlamydia trachomatis is an obligate intracellular bacterium whose only natural host is humans. Although presenting as asymptomatic in most women, genital tract chlamydial infections are a leading cause of pelvic inflammatory disease, tubal factor infertility, and ectopic pregnancy.C. trachomatis has evolved successful mechanisms to avoid destruction by autophagy and the host immune system and persist within host epithelial cells. The intracellular form of this organism, the reticulate body, can enter into a persistent nonreplicative but viable state under unfavorable conditions. The infectious form of the organism, the elementary body, is again generated when the immune attack subsides. In its persistent form,C. trachomatis ceases to produce its major structural and membrane components, but synthesis of its 60-kDa heat shock protein (hsp60) is greatly upregulated and released from the cell. The immune response to hsp60, perhaps exacerbated by repeated cycles of productive infection and persistence, may promote damage to fallopian tube epithelial cells, scar formation, and tubal occlusion. The chlamydial and human hsp60 proteins are very similar, and hsp60 is one of the first proteins produced by newly formed embryos. Thus, the development of immunity to epitopes in the chlamydial hsp60 that are also present in the corresponding human hsp60 may increase susceptibility to pregnancy failure in infected women. Delineation of host factors that increase the likelihood that C. trachomatis will avoid immune destruction and survive within host epithelial cells and utilization of this knowledge to design individualized preventative and treatment protocols are needed to more effectively combat infections by this persistent pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“turned to the cytoplasm for reutilization by the cell (10).”
BackgroundLindquist, S., & Craig, E. A. (1988) · Annual Review of Genetics · doi:10.1146/annurev.ge.22.120188.003215 · Cited by 5,284
Vaginal microbiome of reproductive-age women
Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S. K., McCulle, S. L., Karlebach, S., Gorle, R., Russell, J., Tacket, C. O., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002611107 · Cited by 4,254 · cited 1×
“Lactobacilli dominate the vaginal microbiome in the majority of reproductive-age women (38), but not in any other mammal, including nonhuman primates (39, 40).”
BackgroundPerez-Muñoz, M. E., Arrieta, M.-C., Ramer-Tait, A. E., & Walter, J. (2017) · Microbiome · doi:10.1186/s40168-017-0268-4 · Cited by 1,096
Evidence that the endometrial microbiota has an effect on implantation success or failure
Moreno, I., Codoñer, F. M., Vilella, F., Valbuena, D., Martinez-Blanch, J. F., Jimenez-Almazán, J., Alonso, R., Alamá, P., Remohí, J., Pellicer, A., et al. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.075 · Cited by 868
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection
Scholes, D., Stergachis, A., Heidrich, F. E., Andrilla, H., Holmes, K. K., & Stamm, W. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342103 · Cited by 847
Risk of Sequelae after Chlamydia trachomatis Genital Infection in Women
Haggerty, C. L., Gottlieb, S. L., Taylor, B. D., Low, N., Xu, F., & Ness, R. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/652395 · Cited by 657 · cited 1×
“following a chlamydial infection appear to be low (54).”
BackgroundChlamydia cell biology and pathogenesis
Elwell, C., Mirrashidi, K., & Engel, J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.30 · Cited by 651 · cited 1×
“Whether present in semen from an infected male partner or released from infected female genital tract epithelial cells, the EBs initially bind to heparin sulfate proteoglycans on epithelial cells, followed by interaction with a seemingly wide variety of cell surface receptors: mannose receptor, mannose-6-phosphate rec…”
BackgroundThe role of mannose-binding lectin in health and disease
Turner, M. W. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00155-x · Cited by 634 · cited 1×
“possessing cell surface MBL receptors (48, 49).”
The chlamydial developmental cycle: Figure 1
AbdelRahman, Y. M., & Belland, R. J. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2005.03.002 · Cited by 631 · cited 1×
“When the RB-filled inclusion reaches a critical volume, coinciding with a decreasing pool of nutrients and ATP, the conversion of RBs back to EBs occurs (6).”
Background
Cited by
Sexually transmitted infections and female reproductive health
Van Gerwen, O. T., Muzny, C. A., & Marrazzo, J. M. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01177-x · Cited by 224
Wi, T. E., Ndowa, F. J., Ferreyra, C., Kelly‐Cirino, C., Taylor, M. M., Toskin, I., Kiarie, J., Santesso, N., & Unemo, M. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25343 · Cited by 183
“CT infection remains the most prevalent bacterial STI [5] and is often asymptomatic [64,65].”
BackgroundChowdhury, N. B., Pokorzynski, N., Rucks, E. A., Ouellette, S. P., Carabeo, R. A., & Saha, R. (2024) · mSystems · doi:10.1128/msystems.00717-24 · Cited by 3
Metadata
- Authors
- Witkin, S. S., Minis, E., Athanasiou, A., Leizer, J., & Linhares, I. M.
- Venue
- Clinical and Vaccine Immunology
- Publisher
- American Society for Microbiology
- Published
- 2017-10
- Volume
- 24
- Issue
- 10
- ISSN
- 1556-679X (ISSN-L)
- 1556-6811
- OpenAlex
- W2748465198
- Cited by
- 206
- References
- 83
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.